Lonza · 2 weeks ago
QC Analyst II, Cell Therapy (PM Shift)
Houston, TX
Full-time
Onsite
Mid LevelLonza is a global leader in life sciences, dedicated to manufacturing the medicines of tomorrow. They are seeking a QC Analyst II to perform Quality Control assays for product release of cell therapy products and ensure compliance with cGMP regulations.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Use extensive knowledge of defined SOPs & policies to make sound decisions
Record test results and maintain raw data accurately
Effectively present information and ideas, facilitating understanding among team members
Provide constructive suggestions for improving documentation and workflows
Dependable and excels in a collaborative team environment
Support the development of others through mentoring and training
Qualification
Required
Demonstrated knowledge in biological, cell-based assays, including flow cytometry required
Demonstrated ability to complete methods/procedures and operate specialized lab equipment
Perform tasks with strict adherence to cGMP and cGDP principles
Capable of maintaining and troubleshooting basic and specialized lab equipment
In-depth understanding of cGMP principles, with the ability to identify breaches and suggest corrective actions
Developing Subject Matter Expertise, recognized as a reliable information source by less experienced analysts
Proficient in using spreadsheets, databases, and word processing software
Bachelor's degree in a relevant science field
Benefits
Performance-related bonus.
Medical, dental and vision insurance.
401(k) matching plan.
Life insurance, as well as short-term and long-term disability insurance.
Employee assistance programs.
Paid time off (PTO).
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Founded in 1897
10001+ employees
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Leadership Team
Wolfgang Wienand
Chief Executive Officer
Alfons Ehinger
Founder
Recent News
2026-01-07
2026-01-05
Company data provided by crunchbase